Can seladelpar serve as second-line treatment for PBC patients with inadequate UDCA therapy?

A new second-line therapy for Primary Biliary Cholangitis: Elafibranor

December 13, 2024

SCOPE Index

October 23, 2022

Do Steroids Improve Outcomes After Kasai Hepatoportoenterostomy

September 13, 2022